Trial Profile
Levosalbutamol vs salbutamol in patients with acute exacerbation of COPD or asthma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Nov 2011
Price :
$35
*
At a glance
- Drugs Levosalbutamol (Primary) ; Salbutamol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms X-ACT
- 18 Nov 2011 New trial record
- 27 Oct 2011 Interim results presented at the 77th Annual Meeting of the American College of Chest Physicians: Chest 2011.